Viscovery powers COPD decision support system
[News Viscovery]
Marburg (DE) / Trondheim (NO) / Maastricht (NL) / Horn (NL) / Vienna (AT), 1 July 2018 Viscovery and our transnational group of scientific and clinical collaborators just started the interdisciplinary project ERACo SysMed-COPD.
The main aim of this project is to develop a clinical decision support system for chronic obstructive pulmonary disease (COPD), which will help doctors and medical staff to find the best therapeutic option for the individual patient. Data about several thousand patients from different patient cohorts at different clinics will be used to build a model for identifying possible risk factors and expectable outcomes to respiratory therapy.
The project is part of the EU framework ERACoSysMed for Systems Medicine to address clinical needs and is co-funded by the national funding institutions
- Bundesministerium für Bildung und Forschung (BMBF), Germany,
- The Austrian Science Fund (FWF), Austria,
- The Research Council of Norway (RCN), Norway,
- Zorgonderzoek Nederland (ZON), Netherlands.
Read more about the project at www.uni-marburg.de.
Viscovery powers Big Data visualization with new software release
[News Viscovery]
Vienna / Austria, 31 May 2017 Data mining and data visualization specialist Viscovery Software GmbH has released version 7.1 of its visual data-mining suite Viscovery® SOMine. It comes with a unique innovation that empowers exploration of Big Data faster than ever.
Besides numerous usability improvements, the new SOMine version provides various additional functionality: visual exploration of multivariate Big Data, analysis of multiple attribute correlations, determination of score groups with maximal response, and the option to display thumbnail images associated to the ordered data records in the Viscovery model map. The complete list of innovations is available at viscovery.net/data-sheets.
Interactive exploration of Big Data has been made possible by allowing arbitrary numbers of records to be represented in Viscovery maps. The innovation is based on Viscovery maps as representations for large data distributions which, although created from samples of the data, are nevertheless applicable to the entirety of the data. The map visualization provides instantaneous descriptive statistics as well as real-time access to original data records. Clusters and statistical profiles can be created, modified and determined in fractions of a second, even for very large datasets. This opens the world of interactive data exploration to Big Data.
Visit the Viscovery website to learn from an example how data scientists used the power of the Viscovery Big Data feature to rapidly visualize and explore tens of millions of US mortality records – with surprising results.
Viscovery reports fiscal success for 2016
[News Viscovery]
Vienna / Austria, 30 May 2017 For the fifth time in succession, data mining and data visualization specialist Viscovery Software GmbH reports a significant net profit for the last fiscal year, in which the equity ratio rose to 45%. Business in life sciences continued to develop very well: the share of joint offering projects in total revenues increased again in 2016, and the overall share of consulting service revenues in total revenues amounted to 26%.
In cooperation with its parent company, Biomax Informatics AG, ongoing projects with international clients have met with continued success. Several new license customers were gained, including First Quantum Minerals in Australia, Kojima Industries Corporation in Japan, and the International Finance Corporation in the USA. In addition to the Deloitte consulting group, which have been Viscovery users for many years, PricewaterhouseCoopers has now also chosen Viscovery® SOMine for their analytics services.
Finally, Viscovery continued its penetration of the University and Science market. Numerous universities worldwide acquired Viscovery SOMine licenses for research work, including the University of Bremen, Osaka University and the Nagaoka College. Academic business is particularly beneficial as a long-term driver to generate commercial business. By the end of 2016, more than 800 universities and scientific institutions worldwide have licensed Viscovery SOMine.
Viscovery reports best fiscal year
[News Viscovery]
Vienna / Austria, 14 June 2016 Data mining and data visualization specialist Viscovery Software GmbH reports 2015 was the best fiscal year in the history of the company. Both revenues and equity ratio increased significantly, with the net profit margin rising to 37%. The overall share of consulting services in total revenues was about 15%.
This successful result was mainly due to business successes in life sciences which, in cooperation with parent company Biomax Informatics AG, continued to develop well in 2015. Besides ongoing project business with the Centre of Expertise for Chronic Organ Failure (CIRO+) in the Netherlands, substantial revenues resulted from new business in the biotech sector, in particular in the USA.
In addition to revenues from joint-offering projects, local project services and software maintenance, income was produced by new license customers, such as Mead Johnson in the USA, the Transport Accident Commission in Australia, the National Institute for Environmental Studies in Japan, the IT solution provider SHI International in the UK, and the Ministry of Finance in Singapore.
Numerous universities worldwide purchased Viscovery SOMine licenses for research, including the King’s College London, Vilnius University, Universiti Sains Malaysia, and Shizuoka University in Japan.